Management of Children With Hereditary Angioedema Due to C1 Inhibitor Deficiency
Authors:
- Michael M. FrankMFMichael M. Frank
- Bruce ZurawBZBruce Zuraw
- US Hereditary Angioedema Association Medical Advisory BoardUBUS Hereditary Angioedema Association Medical Advisory Board
- 1 November 2016
- journal article
- review article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 138 (5) , e20160575
Abstract
Hereditary angioedema (HAE) is a potentially life-threatening inherited disease characterized by attacks of skin swelling, severe abdominal pain, and upper airway swelling. Attacks typically begin in childhood, but the appropriate diagnosis is often missed. Attacks do not respond to epinephrine, antihistamines, or glucocorticoids. Recently, many effective drugs have been approved for treatment of adults with HAE, and the Medical Advisory Board of the HAE Patient’s Association has developed and reported treatment recommendations for adults. Only 1 medication is approved for treatment of children <12 years of age, and there are no reported consensus recommendations for treatment of young children in the United States. The 11-member Medical Advisory Board, with extensive experience in the treatment of children, in concert with the leaders of the HAE Patient’s Association, has developed these consensus recommendations to help in recognition, diagnosis, treatment of attacks, and prophylaxis of children with HAE.Keywords
This publication has 57 references indexed in Scilit:
- US Hereditary Angioedema Association Medical Advisory Board 2013 Recommendations for the Management of Hereditary Angioedema Due to C1 Inhibitor DeficiencyThe Journal of Allergy and Clinical Immunology: In Practice, 2013
- Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in EuropeAllergy, Asthma & Clinical Immunology, 2013
- Treatment of attacks with plasma-derived C1-inhibitor concentrate in pediatric hereditary angioedema patientsJournal of Allergy and Clinical Immunology, 2013
- Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiencyJournal of Allergy and Clinical Immunology, 2012
- Hereditary angioedema (HAE) in children and adolescents—a consensus on therapeutic strategiesEuropean Journal of Pediatrics, 2012
- C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks - final results of the I.M.P.A.C.T.2 studyAllergy, 2011
- Home therapy with intravenous human C1‐inhibitor in children and adolescents with hereditary angioedemaTransfusion, 2011
- Hereditary Angioedema in ChildhoodPediatric Drugs, 2010
- Pediatric hereditary angioedema due to C1-inhibitor deficiencyAllergy, Asthma & Clinical Immunology, 2010
- Hereditary AngioedemaNew England Journal of Medicine, 2008